Long-Term Outcome After Bilateral Perinatal Arterial Ischemic Stroke.


Journal

Pediatric neurology
ISSN: 1873-5150
Titre abrégé: Pediatr Neurol
Pays: United States
ID NLM: 8508183

Informations de publication

Date de publication:
12 2019
Historique:
received: 10 06 2019
revised: 24 07 2019
accepted: 26 07 2019
pubmed: 10 9 2019
medline: 25 8 2020
entrez: 10 9 2019
Statut: ppublish

Résumé

We aimed to characterize the phenotype and outcome of children with bilateral, large vessel perinatal arterial ischemic stroke. Patients with bilateral, large vessel perinatal arterial ischemic stroke were identified from a large, population-based cohort (Alberta Perinatal Stroke Project). Subjects were included if stroke involving a major cerebral artery territory was documented in both cerebral hemispheres on magnetic resonance imaging. Standardized variables were extracted from charts including clinical presentations, associated potential risk factors, and outcomes. Outcome measures included the Pediatric Stroke Outcome Measure, Gross Motor Function Classification System, and epilepsy frequency score. Electroencephalographies were reviewed for sleep, epileptiform activity, and background. Of 174 children with perinatal arterial ischemic stroke, eight (5%) had bilateral large artery infarcts. Patients were followed for a mean of 9.7 years (range 1.8 to 14.6 years). One child died. All children had a total Pediatric Stroke Outcome Measure of ≥2 (median 8, range 2 to 10) and Gross Motor Function Classification System ≥ II. Seven of eight (88%) children had a history of epilepsy. Children with bilateral, large vessel perinatal stroke are at high risk of severe cognitive and motor sequelae. Epilepsy may also be more common than unilateral strokes. Cautious discussions with families regarding prognosis are recommended.

Identifiants

pubmed: 31495662
pii: S0887-8994(19)30587-9
doi: 10.1016/j.pediatrneurol.2019.07.013
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

39-42

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Aleksandra Mineyko (A)

Section of Neurology, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada; Section of Neurology, Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada. Electronic address: Aleksandra.mineyko@albertahealthservices.ca.

Adam Kirton (A)

Section of Neurology, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada; Section of Neurology, Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH